Two int'l stem cell projects launched   

两项中外合作干细胞基因测序及研究项目在深启动

包括对心肌细胞和肝细胞进行基因测序及表观遗传分析在内的两项干细胞合作项目12日在深圳启动，以推进干细胞检测方法在药物发现和毒性测试中的应用。

Shenzhen (CNS) -- Two projects involving genomic sequencing and epigenetic inheritance analysis of cardiomyocytes and hepatic cells were launched on Tuesday, in order to promote the application of stem cell detection methods for drug inventions and toxicity tests.

The Beijing Genomics Institute and GE Healthcare Worldwide signed a cooperation agreement and plan for the two hi-tech projects.

The results are likely to lower the invention costs of safer classes of drugs by means of distinguishing predictable genomic cell models, said Dr. Amr Abid with the GE Healthcare.